Endometrial Evaluation in Cases of Postmenopausal Bleeding
1 other identifier
observational
100
0 countries
N/A
Brief Summary
The aim of this prospective observational study is to evaluate abnormal uterine bleeding in postmenopausal women using 3D(dimensional) ultrasound assessment of endometrial volume .Doppler assessment of endometrium and hysteroscopy and to correlate this finding with pathological finding of endometrial biopsy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2019
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2019
CompletedFirst Submitted
Initial submission to the registry
February 9, 2019
CompletedFirst Posted
Study publicly available on registry
February 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedFebruary 20, 2019
February 1, 2019
7 months
February 9, 2019
February 18, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
accuracy of 3d ultrasound in post menopausal bleeding
to evalute women with postmenpausal uterine bleeding using three dimensional ultrasound assessment of endometrial volume
6months
Secondary Outcomes (1)
comparison between hysteroscopy and ultrasound in post menopausal bleeding
6months
Interventions
to evalute abnormal uterine bleeding in postmenopausal women using 3D(dimensional) ultrasound assessment of endometrial volume .Doppler assessment of endometrium and hysteroscopy and to correlate this finding with pathological finding of endometrial biopsy
Eligibility Criteria
Women Age \> 45 years postmenopausal uterine bleeding
You may qualify if:
- Women Age \> 45 years
- with postmenopausal uterine bleeding
You may not qualify if:
- Women with bleeding disorders or coagulopathy
- women with cervical cancer or breast carcinoma .
- history of tamoxifen intake
- women with fibroid .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Related Publications (2)
Goldstein SR. Modern evaluation of the endometrium. Obstet Gynecol. 2010 Jul;116(1):168-176. doi: 10.1097/AOG.0b013e3181dfd557.
PMID: 20567184BACKGROUNDJacobs I, Gentry-Maharaj A, Burnell M, Manchanda R, Singh N, Sharma A, Ryan A, Seif MW, Amso NN, Turner G, Brunell C, Fletcher G, Rangar R, Ford K, Godfrey K, Lopes A, Oram D, Herod J, Williamson K, Scott I, Jenkins H, Mould T, Woolas R, Murdoch J, Dobbs S, Leeson S, Cruickshank D, Skates SJ, Fallowfield L, Parmar M, Campbell S, Menon U. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol. 2011 Jan;12(1):38-48. doi: 10.1016/S1470-2045(10)70268-0. Epub 2010 Dec 10.
PMID: 21147030BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Ahmed Aref
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assisant lecturer
Study Record Dates
First Submitted
February 9, 2019
First Posted
February 20, 2019
Study Start
February 1, 2019
Primary Completion
September 1, 2019
Study Completion
October 1, 2019
Last Updated
February 20, 2019
Record last verified: 2019-02